A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)
Clinical trial NCT05133518 · COMPLETED
Trial details
- NCT number
- NCT05133518
- Sponsor
- Melt Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-20
- Primary completion
- 2022-10-26
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.